ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,433Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 3734

$796K Total Retail Price of All Prescriptions

Rank: 223 out of 3734

338 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 15,430 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL TARTRATE 722 677 1 6
PRAVASTATIN SODIUM 538 495 2 15
OMEPRAZOLE 523 502 3 4
LOSARTAN POTASSIUM 469 440 4 21
AMLODIPINE BESYLATE 456 431 5 5
ZOLPIDEM TARTRATE 435 402 6 24
LISINOPRIL 373 337 7 3
MECLIZINE HCL 363 353 8 139
ISOSORBIDE MONONITRATE ER 355 352 9 34
GLIMEPIRIDE 343 327 10 37
DOXAZOSIN MESYLATE 327 312 11 100
JANUVIA 281 264 12 50
TRAMADOL HCL 275 267 13 20
RANITIDINE HCL 268 246 14 32
LEVOTHYROXINE SODIUM 265 265 15 2
BYSTOLIC 265 263 15 148
FUROSEMIDE 238 233 17 7
SIMVASTATIN 233 218 18 1
ATENOLOL 223 201 19 13
ATORVASTATIN CALCIUM 207 206 20 11
GABAPENTIN 194 185 21 17
CRESTOR 184 167 22 28
WARFARIN SODIUM 181 177 23 10
ZETIA 175 154 24 55
ONGLYZA 172 168 25 211
AMLODIPINE BESYLATE-BENAZEPRIL 168 168 26 56
DIOVAN 166 154 27 31
JANUMET 162 141 28 180
TORSEMIDE 157 153 29 160
NEXIUM 156 142 30 36
NITROSTAT 155 155 31 237
PLAVIX 153 153 32 39
METFORMIN HCL 152 141 33 8
LOSARTAN-HYDROCHLOROTHIAZIDE 143 142 34 71
METOPROLOL SUCCINATE 139 139 35 14
CLOPIDOGREL 125 125 36 23
LOVAZA 119 118 37 143
AMMONIUM LACTATE 116 100 38 332
SINGLE USE SWAB 113 91 39 292
FAMOTIDINE 111 110 40 60
LACTULOSE 107 92 41 137
NAMENDA 104 104 42 44
LANSOPRAZOLE 101 89 43 155
SYNTHROID 101 95 43 47
CELEBREX 101 94 43 69
CARVEDILOL 98 97 46 30
ALLOPURINOL 98 98 46 33
LIPITOR 97 97 48 90
DIOVAN HCT 95 84 49 72
NIFEDIPINE ER 94 94 50 113
TAMSULOSIN HCL 94 85 50 29
COUMADIN 93 93 52 206
SERTRALINE HCL 91 74 53 18
POLYETHYLENE GLYCOL 3350 91 86 53 53
INDAPAMIDE 90 80 55 218
PROCTOZONE-HC 89 89 56 438
LOVASTATIN 82 77 57 41
MUPIROCIN 77 75 58 189
BENAZEPRIL HCL 76 76 59 103
ALCOHOL SWABS 72 46 60 290
TERAZOSIN HCL 72 72 60 136
CLOTRIMAZOLE-BETAMETHASONE 71 65 62 135
FEXOFENADINE HCL 66 59 63 347
COLCRYS 66 66 63 216
IBUPROFEN 65 56 65 75
NASONEX 63 63 66 239
LIDODERM 61 61 67 170
POTASSIUM CHLORIDE 61 61 67 19
DONEPEZIL HCL 60 57 69 25
AMOXICILLIN 59 48 70 108
ESCITALOPRAM OXALATE 56 56 71 68
HYDROCHLOROTHIAZIDE 55 43 72 9
SINGULAIR 53 48 73 95
CHLORHEXIDINE GLUCONATE 53 53 73 260
PANTOPRAZOLE SODIUM 53 46 73 22
ADVAIR DISKUS 52 43 76 35
AZOR 51 51 77 232
KETOCONAZOLE 51 50 77 204
CLONIDINE HCL 51 51 77 79
FLUTICASONE PROPIONATE 50 50 80 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.